Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,806.40
(
0.76%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
104.32
(
0.13%
)
Bitcoin
81,532.14
(
0.59%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

md1225

Send PM Follow Ignore
Followers 98
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

md1225

Re: nuke661 post# 243102

Wednesday, 11/18/2015 2:11:29 PM

Wednesday, November 18, 2015 2:11:29 PM

Post# of 347009
Yes nuke and best of all is bavi will allow all patients to benefit from nivolumab or durvolumab we will see 20 months average mos with many CRs when Bavituximab is added.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote